GlassScriptPhysician profile
Sathish Kumar Kumar Krishnan
NPI 1508121492
$5,203.95
in general payments reported to CMS, 2019-2025
36 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $168 · 2021: $12.35 · 2022: $269 · 2023: $2,039 · 2024: $533 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,107 · Travel and Lodging: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.69 |
| Travel and Lodging | $1,485.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,595.18 | 2023 | Single Use Suction Valve (Sterile), Single Use Electrosurgical Knife Kd-655, Single Use Electrosurgical Hemostatic Forceps |
| Glaxosmithkline, LLC. | $441.18 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.46 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $276.34 | 2022-2025 | |
| Grifols USA, LLC | $238.01 | 2019-2025 | Prolastin-C Liquid |
| Boston Scientific Corporation | $206.53 | 2025 | Ekosonic |
| Pulmonx Corporation | $166.13 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Abbvie INC. | $156.73 | 2025 | |
| Sunovion Pharmaceuticals INC. | $156.36 | 2019 | |
| United Therapeutics Corporation | $151.87 | 2024-2025 | Remodulin, Orenitram, Tyvaso |
| Astrazeneca Pharmaceuticals LP | $144.27 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Regeneron Healthcare Solutions, INC. | $122.82 | 2019-2024 | Dupixent |
| Mylan Specialty L.P. | $101.59 | 2019-2023 | Yupelri |
| Pfizer INC. | $100.97 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $99.80 | 2019-2025 | Winrevair |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $97.97 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $97.16 | 2019-2024 | Opsumit, Uptravi |
| Genentech USA, INC. | $89.95 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $59.50 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.78 | 2023-2025 | Glassia |
| Electromed, INC. | $56.33 | 2022-2025 | Smartvest |
| Gilead Sciences, INC. | $50.55 | 2019 | |
| Harmony Biosciences LLC | $48.38 | 2023-2024 | Wakix |
| Janssen Pharmaceuticals, INC | $36.71 | 2022-2023 | Xarelto |
| Insmed, INC. | $35.65 | 2024-2025 | Brinsupri, Arikayce |
| Resmed Corp | $34.12 | 2022-2023 | |
| Advanced Respiratory, INC | $30.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.35 | 2019 | |
| Inspire Medical Systems, INC. | $29.63 | 2025 | Inspire |
| Viatris Specialty LLC | $29.55 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $27.25 | 2024 | Acthar |
| Amgen INC. | $25.10 | 2024 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $24.27 | 2024 | Lumryz |
| Philips North America LLC | $20.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.46 | 2020 | |
| Shire North American Group INC | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sathish Kumar Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.